Wynnefield Partners Small Cap Value, L.P. I 13D and 13G filings for :
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2020-11-03 4:23 pm Purchase | 2020-11-03 | 13D | MusclePharm Corporation MSLP | Wynnefield Partners Small Cap Value, L.P. I | 2,111,874 6.400% | 100,000 (+4.97%) | Filing |
| 2020-10-28 3:57 pm Sale | 2020-10-26 | 13D | MusclePharm Corporation MSLP | Wynnefield Partners Small Cap Value, L.P. I | 2,011,874 6.100% | -31 (-0.00%) | Filing |
| 2020-07-13 2:07 pm Purchase | 2020-07-13 | 13D | MusclePharm Corporation MSLP | Wynnefield Partners Small Cap Value, L.P. I | 2,011,905 6.200% | 80,600 (+4.17%) | Filing |